dbo:abstract
|
- THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole. (en)
|
dbo:casNumber
| |
dbo:fdaUniiCode
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 6525 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chemspiderid
| |
dbp:f
| |
dbp:h
| |
dbp:iupacName
|
- [1--1H-indazol-3-yl]methanone (en)
|
dbp:legalCa
| |
dbp:legalDe
| |
dbp:legalUk
| |
dbp:legalUs
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:smiles
|
- c1ccc2ccccc2Cc3c4ccccc4nCCCCCF (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- DULWRYKFTVFPTL-UHFFFAOYSA-N (en)
|
dbp:unii
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- THJ-2201 is an indazole-based synthetic cannabinoid that presumably acts as a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is a structural analog of AM-2201 in which the central indole ring has been replaced by indazole. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |